Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Current status and capacity of pathogen laboratories in centers for disease control and prevention in China during the Covid-19 pandemic

A nationwide cross-sectional survey

Bibliographic Data

ID22076032
AuthorsJi Wang (0000-0002-3447-9107, Chinese Center For Disease Control and Prevention), Peihua Niu (0000-0001-5930-4234, National Institute for Viral Disease Control and Prevention), Ruiqing Zhang (0000-0002-5087-2734, National Institute for Viral Disease Control and Prevention), Jingyi Li (0009-0008-6009-6055, National Institute for Viral Disease Control and Prevention), Mingzhu Nie (National Institute for Viral Disease Control and Prevention), Xuejun Ma (0000-0002-1292-3449, Chinese Academy of Sciences, corresponding author)
Year2022
Volume10
Pages927318-927318
Publication date2022-08-11
Open AccessYes
TypeARTICLE
VenueFrontiers in Public Health (JOURNAL)
Journal identifiersISSN: 2296-2565 • E-ISSN: 2296-2565
PublisherFrontiers Media SA (PUBLISHER • CH)
DOI10.3389/fpubh.2022.927318
PMID36033752
OpenAlexW4291018738
LanguageEN
Citations received2
References cited18

The pathogen laboratory (p-lab) is the core and primary department of centers for disease control and prevention (CDCs) in China to respond to infectious disease outbreaks such as COVID-19. To understand the current status and capacity of p-labs in Chinese CDCs during the COVID-19 pandemic, we conducted a nationwide cross-sectional survey among 399 respondents from 239 CDCs. Differences in the current status of p-labs in CDCs of provinces, cities, and counties mainly comprised laboratory equipment, IEIs, mastery of personal occupational skills, and maximum detection capacity. Most CDCs reported a lack of staff and funds for personnel, which should be a priority in China's upcoming public health reform. The development of sequencing technologies has received considerable attention in CDCs. These are mainly used to study respiratory viruses such as influenza and SARS-CoV-2. The COVID-19 pandemic has driven development of the CDCs in China, and personnel and funds are considered key factors in improving the detection capacity of CDC p-labs

China · Cross-sectional study · Disease · Disease control · Environmental health · Geography · Infection control · Intensive care medicine · Outbreak · Pandemic · Pathology · Personal protective equipment · Public health · COVID-19 epidemiological studies · Medicine · Nursing · SARS-CoV-2 detection and testing · Viral Infections and Outbreaks Research · Virology

  • The state of biosafety across China's CDC microbiology laboratories

    Open Access•Peihua Niu, Zhenlu Sun et al.•Frontiers in Public Health•2024

  • Three-year nationwide survey of microbiology laboratory equipment conditions in China’s CDC

    Open Access•Peihua Niu, Zhenlu Sun et al.•Frontiers in Public Health•2026

  • Successful Elimination of Covid-19 Transmission in New Zealand

    Michael G Baker, Nick Wilson et al.•New England Journal of Medicine•2020

  • Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

    Open Access•Victor M Corman, Olfert Landt et al.•Eurosurveillance•2020

  • Health security capacities in the context of Covid-19 outbreak

    Open Access•Nirmal Kandel, Stella Chungong et al.•The Lancet•2020

  • Institutions and the uneven geography of the first wave of the Covid‐19 pandemic

    Open Access•Andrés Rodríguez-Pose, Chiara Burlina•Journal of Regional Science•2021

Citations per year1
Citation span2024 - 2026 (3)
Highly citedNo

Tools

Open DOIOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae